within Pharmacolibrary.Drugs.ATC.J;

model J01EE03
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.85,
    Cl             = 2.4 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 400 / 1000000,
    adminCount     = 1,
    Vd             = 0.0012,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.018333333333333333,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Sulfametrole and trimethoprim is a fixed combination antibacterial drug containing the sulfonamide sulfametrole and the dihydrofolate reductase inhibitor trimethoprim. This combination is used to treat a variety of bacterial infections, including urinary and respiratory tract infections. The combination is similar in therapeutic approach to sulfamethoxazole/trimethoprim (co-trimoxazole), but is less commonly used today and is not approved in all countries.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameter estimates for healthy adult volunteers, oral administration.</p><h4>References</h4><ol><li><p>Vouloumanou, EK, et al., &amp; Falagas, ME (2011). Trimethoprim/sulfametrole: evaluation of the available clinical and pharmacokinetic/pharmacodynamic evidence. <i>International journal of antimicrobial agents</i> 38(3) 197–216. DOI:<a href=&quot;https://doi.org/10.1016/j.ijantimicag.2011.04.016&quot;>10.1016/j.ijantimicag.2011.04.016</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/21741802/&quot;>https://pubmed.ncbi.nlm.nih.gov/21741802</a></p></li><li><p>Guggenbichler, JP, et al., &amp; Rohrer, R (1981). [Pharmacokinetic of antibiotics in patients with mucoviscidosis (author&#x27;s transl)]. <i>Padiatrie und Padologie</i> 16(4) 393–402. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/7301388/&quot;>https://pubmed.ncbi.nlm.nih.gov/7301388</a></p></li><li><p>Guggenbichler, JP, &amp; Takacs, F (1980). [Relative clinical biological availability of a combination of trimethoprim-sulfamethoxazole in fasting children and after a meal]. <i>Padiatrie und Padologie</i> 15(4) 305–320. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/7007989/&quot;>https://pubmed.ncbi.nlm.nih.gov/7007989</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end J01EE03;
